- The Dow Jones Industrial Average added 104.09 points, or 0.35%.
- The S&P 500 put on10.29 points, or 0.28%.
- The Nasdaq Composite gained 62.83 points, or 0.5%, to 12,582.77.
The benchmarks battled back and ended higher on Tuesday, with the S&P and Nasdaq setting record highs.
Stocks were lifted, notably in the healthcare sector on positive COVID-19 vaccine news although there were mixed sentiments surrounding fiscal stimulus progress.
The Dow Jones Industrial Average rose 104.09 points, or 0.35%, to 30,173.88, the S&P 500 added 10.29 points, or 0.28%, to 3,702.25 and the Nasdaq Composite gained 62.83 points, or 0.5%, to 12,582.77.
Johnson & Johnson JNJ added 1.73% which helped to underpin the benchmarks with the company announcing that it could obtain late-stage trial results of the single-dose COVID-19 vaccine earlier than expected.
Meanwhile, Pfizer Inc PFE advanced 3.18% as it cleared the next hurdle in the race to get its COVID19 vaccine approved for emergency use.
The US health regulator released documents raising no new safety or efficacy issues.
Elsewhere, a Brexit deal remains elusive. Chance of a deal is slimming with negotiators from both sides acknowledging a deal may not be achieved.
''The next 24 hours will be critical and is likely to cause market volatility depending on what is or isn’t agreed,'' analysts at ANZ Bank explained.
US data
The analysts at ANZ Bank explained that small businesses optimism in the US fell in November, while Q3 non-farm productivity levels eased and unit labour costs fell.
''While the movements were not drastic, these data all point to a slightly weaker US economy.''
''If wages continue to fall that will be deflationary, however the small business survey showed selling prices were increasing and this data does tend to align with consumer prices.''
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD treads water just above 1.0400 post-US data
Another sign of the good health of the US economy came in response to firm flash US Manufacturing and Services PMIs, which in turn reinforced further the already strong performance of the US Dollar, relegating EUR/USD to the 1.0400 neighbourhood on Friday.
GBP/USD remains depressed near 1.2520 on stronger Dollar
Poor results from the UK docket kept the British pound on the back foot on Thursday, hovering around the low-1.2500s in a context of generalized weakness in the risk-linked galaxy vs. another outstanding day in the Greenback.
Gold keeps the bid bias unchanged near $2,700
Persistent safe haven demand continues to prop up the march north in Gold prices so far on Friday, hitting new two-week tops past the key $2,700 mark per troy ounce despite extra strength in the Greenback and mixed US yields.
Geopolitics back on the radar
Rising tensions between Russia and Ukraine caused renewed unease in the markets this week. Putin signed an amendment to Russian nuclear doctrine, which allows Russia to use nuclear weapons for retaliating against strikes carried out with conventional weapons.
Eurozone PMI sounds the alarm about growth once more
The composite PMI dropped from 50 to 48.1, once more stressing growth concerns for the eurozone. Hard data has actually come in better than expected recently – so ahead of the December meeting, the ECB has to figure out whether this is the PMI crying wolf or whether it should take this signal seriously. We think it’s the latter.
Best Forex Brokers with Low Spreads
VERIFIED Low spreads are crucial for reducing trading costs. Explore top Forex brokers offering competitive spreads and high leverage. Compare options for EUR/USD, GBP/USD, USD/JPY, and Gold.